Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Hemgenix
Pharma
ASH: CSL proves 5-year durability of Hemgenix
After five years of follow-up on its Hemgenix, CSL found that a one-time dose can cut down on annualized bleeding rates by 90% by year five.
Zoey Becker
Dec 7, 2025 12:00pm
UPDATED: Most expensive drugs in the US in 2025
Aug 11, 2025 3:00am
As Pfizer bows out, CSL keeps hemophilia gene therapy hopes alive
Apr 11, 2025 10:32am
UniQure sells gene therapy manufacturing facility to Genezen
Jul 1, 2024 10:46am
Pfizer charges $3.5M for its first FDA-approved gene therapy
Apr 26, 2024 10:19am
Record plasma collections spark a revenue boost for CSL
Aug 16, 2023 11:32am
